ENZON PHARMS INC (ENZN) earnings
ENZN earnings moved a median of 0.00% by the close. Quarterly and annual ENZN reports and results, each read against the price at its own news timestamp. Back to the ENZN overview →
12 measured ENZN earnings events.
Where these ENZN earnings landedvs 10 measured ENZN earnings reactions
| Middle 50% of ENZN earnings reactions | -2.20% to +5.26% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 ENZN earnings events with a measured close landed between -2.20% and +5.26%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +11.11% | — | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +3.95% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +7.53% | |
| Form 10-K/A ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.69% | |
| Form 10-K ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -10.00% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -5.65% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | -6.06% | -2.94% | |
| Form 10-K/A ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-K ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +33.33% | +33.33% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% |
Keep exploring
More ENZN: analyst actions → · SEC filings → · ENZN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Titan Pharmaceuticals, Inc. (TTNP) | 94 | +0.47% | 61% |
| COGNETIVITY NEUROSCIENCES (CGNSF) | 93 | 0.00% | 37% |
| HEMACARE CORP (HEMA) | 91 | 0.00% | 23% |
| Telesis Bio, Inc. (TBIO) | 91 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.